Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapy    save search

Todays' Top-5
Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003
Published: 2023-12-07 (Crawled : 13:00) - globenewswire.com
SLDB | News M | $5.89 72.22% 41.94% 12M twitter stocktwits trandingview |
Health Technology
| | O: 15.25% H: 0.0% C: 0.0%

sgt-003 fda designation duchenne therapy
Visgenx and Charles River Announce Expansion of Gene Therapy Manufacturing Alliance
Published: 2023-12-07 (Crawled : 11:00) - prnewswire.com
CRL | News | $202.77 1.04% 0.0% 430K twitter stocktwits trandingview |
Commercial Services
| | O: 0.01% H: 0.0% C: 0.0%

expansion therapy
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program- IND filing expected in mid-2025 -
Published: 2023-12-06 (Crawled : 20:00) - biospace.com/
VYGR | $7.85 3.15% 3.06% 180K twitter stocktwits trandingview |
Health Technology
| | O: 2.16% H: 0.0% C: 0.0%
SGMO | $0.443 -1.14% -1.15% 850K twitter stocktwits trandingview |
Health Technology
| | O: -4.81% H: 0.0% C: 0.0%
NBIX M | $119.97 0.42% 0.42% 880K twitter stocktwits trandingview |
Health Technology
| | O: 3.02% H: 0.0% C: 0.0%

candidate expected sclerosis therapeutics therapy
Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Published: 2023-12-06 (Crawled : 17:00) - biospace.com/
COYA | $7.27 0.41% 0.41% 64K twitter stocktwits trandingview |
| | O: -6.04% H: 0.0% C: 0.0%

sclerosis treatment collaboration commercialization therapy
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
Published: 2023-12-06 (Crawled : 15:30) - biospace.com/
ZOM | $0.1632 -3.6% 1.72% 3.4M twitter stocktwits trandingview |
Miscellaneous
| Email alert Add to watchlist

pulsevet association presentation meeting therapy
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
Published: 2023-12-06 (Crawled : 14:30) - invobioscience.com
INVO | $1.53 -6.71% -7.19% 240K twitter stocktwits trandingview |
Health Technology
| | O: 3.77% H: 0.0% C: 0.0%

partnership natural cell research therapeutics therapy
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
Published: 2023-12-06 (Crawled : 12:00) - globenewswire.com
VYGR | $7.85 3.15% 3.06% 180K twitter stocktwits trandingview |
Health Technology
| | O: 2.16% H: 0.0% C: 0.0%
SGMO | $0.443 -1.14% -1.15% 850K twitter stocktwits trandingview |
Health Technology
| | O: -4.81% H: 0.0% C: 0.0%
NBIX M | $119.97 0.42% 0.42% 880K twitter stocktwits trandingview |
Health Technology
| | O: 3.02% H: 0.0% C: 0.0%

candidate sclerosis program therapeutics therapy
Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NBIX M | $119.97 0.42% 0.42% 880K twitter stocktwits trandingview |
Health Technology
| | O: 3.02% H: 0.0% C: 0.0%

drug food designation therapy
G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy
Published: 2023-12-05 (Crawled : 14:30) - globenewswire.com
GTHX | $3.16 30.58% 23.42% 10M twitter stocktwits trandingview |
Health Technology
| | O: 9.78% H: 0.0% C: -8.91%

trilaciclib therapeutics therapy
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System
Published: 2023-12-05 (Crawled : 12:30) - prnewswire.com
ARAY A | $2.64 -0.75% -0.76% 440K twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.0% C: 0.0%

radixact sales solution system therapy
Therapy Co. SPAC Investors Fight Del. Stock-Drop Suit Toss – Law360
Published: 2023-12-02 (Crawled : 04:20) - spacfeed.com
APXI | $11.11 0.0% 6 twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

spac therapy
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE)
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
TOT | News | $48.3 0% twitter stocktwits trandingview |
Energy Minerals
| Email alert Add to watchlist

nrtx-1001 cell ongoing trial therapeutics therapy
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
NVS | News 1 d | $95.93 -1.15% 0.0% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 0.0% C: 0.0%
ORTX | $16.27 0.28% 0.28% 54K twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.0% C: 0.0%
GBIO | $1.765 6.33% 5.95% 670K twitter stocktwits trandingview |
Health Technology
| | O: 0.43% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.0% C: 0.0%
AMGN S | $271.33 0.74% 0.73% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 0.0% C: 0.0%
ADAP | $0.5561 -0.96% -0.97% 340K twitter stocktwits trandingview |
Health Technology
| | O: -3.0% H: 0.0% C: 0.0%
ABEO | $4.76 4.61% 4.41% 270K twitter stocktwits trandingview |
Health Technology
| | O: -2.43% H: 0.0% C: 0.0%

research growing therapy market
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
EXAS | News | $64.96 -0.31% -0.31% 930K twitter stocktwits trandingview |
Health Technology
| | O: -2.08% H: 0.0% C: 0.0%

breast symposium cancer sciences therapy
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Published: 2023-11-30 (Crawled : 21:00) - prnewswire.com
EXAS | News | $64.96 -0.31% -0.31% 930K twitter stocktwits trandingview |
Health Technology
| | O: -2.08% H: 0.0% C: 0.0%

breast symposium cancer sciences therapy
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
MS | News 0 d | $80.35 1.18% -0.03% 5.3M twitter stocktwits trandingview |
Finance
| | O: 0.28% H: 0.9% C: 0.72%
ABBV | News | $147.97 1.09% 0.05% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 3.4% C: 3.17%
IMGN M | $29.355 0.05% 0.05% 12M twitter stocktwits trandingview |
Health Technology
| | O: 81.82% H: 0.0% C: 0.0%

elahere abbvie cancer tumor acquire therapy
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
BNTC | $3.365 7.51% 6.98% 4.7K twitter stocktwits trandingview |
Health Technology
| | O: 0.63% H: 8.29% C: -0.63%

bb-301 candidate treatment biopharma trial therapy
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GH M | $26.28 2.1% 2.05% 1M twitter stocktwits trandingview |
Health Services
| | O: 1.51% H: 3.92% C: -1.29%

disease breast health symposium biomarker cancer therapy
Astellas' Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women Considered Unsuitable for Hormone Therapy
Published: 2023-11-29 (Crawled : 00:00) - prnewswire.com
ALPMY | $12.15 0.99% 590K twitter stocktwits trandingview |
Manufacturing
| | O: 0.66% H: 0.0% C: -0.16%
PFE A | $28.63 -0.56% 0.0% 35M twitter stocktwits trandingview |
Health Technology
| | O: 1.71% H: 0.0% C: 0.0%

women therapy hormone
Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development
Published: 2023-11-29 (Crawled : 15:00) - globenewswire.com
BNGO | $1.505 -9.88% -10.96% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 5.23% H: 0.0% C: 0.0%

publication therapy
Gainers vs Losers
69% 31%

Top 10 Gainers
SLDB | News M | $5.89 72.22% 41.94% 12M twitter stocktwits trandingview |
Health Technology

SVFD | News | $3.09 43.72% 30.42% 64M twitter stocktwits trandingview |

FTEL | $2.04 43.66% 30.39% 110K twitter stocktwits trandingview |

HPCO 4 | $0.4824 41.92% 29.54% 28M twitter stocktwits trandingview |

ALGS | News | $0.6475 -5.06% 26.67% 2.1M twitter stocktwits trandingview |
Health Technology

GTHX | $3.16 30.58% 23.42% 10M twitter stocktwits trandingview |
Health Technology

KEQU | $22.5 27.62% 21.64% 24K twitter stocktwits trandingview |
Producer Manufacturing

GSIT | $3.09 27.16% 21.36% 2.2M twitter stocktwits trandingview |
Electronic Technology

SSKN P | $0.628 25.6% 20.38% 210K twitter stocktwits trandingview |
Health Technology

GLUE | $3.66 22.82% 18.58% 510K twitter stocktwits trandingview |
Professional, Scientific, and T...


Your saved searches
Save your searches and get alerts when important news are released.